Metabolic dysfunction associated steatotic liver disease (MASLD)

Kieran Reynolds talks to Arron Jones, Lead Hepatology Pharmacist about metabolic dysfunction associated steatotic liver disease (MASLD). Discussion includes what MASLD/MASH stands for, prevalence, diagnosis, treatment; including advice to give to patients accessing GLP-1 RAs online, and emerging therapies. Arron Jones - Lead Hepatology Pharmacist, Bart’s Health Trust Kieran Reynolds - Advanced Specialist Pharmacist (Medicines Governance), SPS Useful links: The British Liver Trust’s information on MASLD, NAFLD and fatty liver disease https://britishlivertrust.org.uk/information-and-support/liver-conditions/masld-nafld-and-fatty-liver-disease/ The NHS Eatwell Guide https://www.nhs.uk/live-well/eat-well/food-guidelines-and-food-labels/the-eatwell-guide/ The South Asian Eatwell Guide https://mynutriweb.com/the-south-asian-eatwell-guide/ SPS article on using statins in liver impairment https://www.sps.nhs.uk/articles/using-statins-in-liver-impairment/ The General Pharmaceutical Council’s FAQs on weight loss medications (including a guide for patients on how to keep safe when getting medicines or treatment online: scroll to bottom of page to access) https://www.pharmacyregulation.org/patients-and-public/standards-you-can-expect-using-pharmacy-services/weight-loss-medications-faq